Vanita R Aroda MD

Endocrinology•Boston, MA

Diabetes, Lipid Metabolism

Physician

Join to View Full Profile

221 Longwood AveBoston, MA 02115
Phone+1 617-732-5666
Fax+1 617-525-0436

Education & Training

University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2001 - 2003
University of California (San Diego) Medical CenterResidency, Internal Medicine, 1998 - 2001
University of California San Diego School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 2000 - Present
MA State Medical License 2017 - 2027
DC State Medical License 2008 - 2018
MD State Medical License 2008 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 2002 Sep 01
Active, not recruiting
Phase 3
Vitamin D and Type 2 Diabetes Study Start of enrollment: 2013 Oct 01
Completed
Not Applicable
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
COMPLETED
NA
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes Start of enrollment: 2020 May 29
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Effect of Oral Semaglutide Versus Comparators on Multiple Cardiometabolic Risk Factor Control in Adults With Type 2 Diabetes.
Vanita R Aroda, Brian Malling, Juris J Meier, Morten T Abildlund, Pranav Kelkar
Diabetes Care. 2025-05-01
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial.
Vanita R Aroda, Nils B Jørgensen, Bharath Kumar, Ildiko Lingvay, Anne Sofie Laulund
Diabetes Care. 2025-04-25
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes.
John B Buse, Steven E Kahn, Vanita R Aroda, Richard J Auchus, Timothy Bailey
Diabetes Care. 2025-04-18

Lectures

Overview and Review of the Diabetes Prevention Program and Design of DPPOS
Vanita R. Aroda, MD - 6/16/2014

Press Mentions

Higher Doses of This Drug May Improve Blood Sugar in Type 2 DiabetesApril 19th, 2025
Can New Drugs Help Millions of Obese Americans?September 30th, 2024
Treating Hyperglycemia in Type 2 DiabetesOctober 10th, 2022
Join now to see all